Arcturus Therapeutics Holdings Inc. (32) | Business Finance (14)

Browse by Subcategory

Recent Contracts

Sixth Amendment to Loan and Security Agreement, dated April 19, 2022, by and between Arcturus Therapeutics, Inc. and Western Alliance Bank (Filed With SEC on May 9, 2022)
Technology License and Technical Support Agreement, signed July 29, 2021 and effective July 30, 2021, by and between Arcturus Therapeutics, Inc. and Vinbiocare Biotechnology Joint... (Filed With SEC on August 10, 2021)
Underwriting Agreement, dated December 7, 2020, by and among Arcturus Therapeutics Holdings Inc., Piper Sandler & Co., Guggenheim Securities, LLC and Wells Fargo Securities, LLC (Filed With SEC on December 8, 2020)
Form of Securities Purchase Agreement, dated September 25, 2019, between the Company and the purchasers party thereto (Filed With SEC on September 27, 2019)
Registration Rights Agreement, dated June 18, 2019, between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on June 20, 2019)
Fifth Amendment to Loan and Security Agreement, dated October 27, 2021, by and between Arcturus Therapeutics, Inc. and Western Alliance Bank (Filed With SEC on November 9, 2021)
Framework Drug Substance Supply Agreement, signed July 29, 2021 and effective July 30, 2021, by and between Arcturus Therapeutics, Inc. and Vinbiocare Biotechnology Joint Stock... (Filed With SEC on August 10, 2021)
Fourth Amendment to Loan and Security Agreement, dated December 1, 2020 (Filed With SEC on December 7, 2020)
Underwriting Agreement, dated July 28, 2020, by and among Arcturus Therapeutics Holdings Inc., Citigroup Global Markets Inc., Guggenheim Securities, LLC, and Barclays Capital Inc (Filed With SEC on July 29, 2020)
Underwriting Agreement, dated April 16, 2020, by and between Arcturus Therapeutics Holdings Inc. and Guggenheim Securities, LLC (Filed With SEC on April 17, 2020)
Third Amendment, dated October 30, 2019, by and between Western Alliance Bank, and Arcturus Therapeutics, Inc. to the Loan and Security Agreement dated as of October 12, 2018.... (Filed With SEC on November 8, 2019)
Securities Purchase Agreement, dated August 2, 2019, between the Company and the Investor (Filed With SEC on August 5, 2019)
Securities Purchase Agreement, dated August 1, 2019, between the Company and the Investors party thereto (Filed With SEC on August 2, 2019)
Equity Purchase Agreement, dated June 18, 2019, between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on June 20, 2019)